Urovance Description

UROVANCE CAPSULES 0.5MG/0.4MG are oblong, hard gelatin capsules, with brown body and beige cap printed with C001 in black ink.
Each hard capsule contains tamsulosin hydrochloride modified-release pellets and one dutasteride soft gelatin capsule.
Each hard capsule contains 0.5 mg dutasteride and 0.4 mg tamsulosin hydrochloride (equivalent to 0.367 mg tamsulosin).
Excipient(s) with known effect: Each capsule contains soya lecithin and propylene glycol.
Excipients/Inactive Ingredients: Hard capsule shell: Black iron oxide (E172), Red iron oxide (E172), Titanium dioxide (E171), Yellow iron oxide (E172), Gelatin.
Contents in dutasteride soft capsule: Propylene glycol monocaprylate (type II), Butylhydroxytoluene (E321).
Soft capsule shell: Gelatin, Glycerol, Titanium dioxide (E171), Triglycerides (medium chain), Lecithin soy.
Tamsulosin pellets: Methacrylic acid - ethyl acrylate copolymer (1:1) dispersion 30 per cent (contains sodium laurilsulfate, polysorbate 80), Microcrystalline cellulose, Dibutyl sebacate, Polysorbate 80, Colloidal hydrated silica, Calcium stearate.
Black ink: Shellac (E904), Black iron oxide (E172), Propylene glycol (E1520), Concentrated ammonia solution (E527), Potassium hydroxide (E525).